3620 results for «2440»
3620 results
EuroPCR 2021 Clinical Research - Waiting for a new meta-analysis of revascularisation versus medical therapy for chronic coronary syndromes: what should we be focusing on?
12 May 2021 – From EuroPCR 2021
Revascularisation vs. medical therapy alone for chronic coronary syndromes: has the issue been settled ? Follow this PCR Clinical Research episode to understand the new findings from the latest meta-analysis!
PCR's Got Talent Winning Submission: POT Puff Study
18 May 2021 – From EuroPCR 2021
Consult this session to discover the winning abstract submitted during the second round of EuroPCR 2021 PCR's Got Talent, a unique abstract competition for young practitioners, and get a concentrate of the POT Puff study!
PCR's Got Talent - Valvular Interventions
18 May 2021 – From EuroPCR 2021
Thanks to the abstracts of this session, find out more about heterotopic caval valve implantation preprocedural assessment, patient-specific computer simulation to predict long-term outcomes after TAVI, and much more!
The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis
18 May 2022 – From EUROPCR 2022
This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.
Calcified lesions: one big challenge; several good options
17 May 2024 – From EuroPCR 2024
This session delves into the management of calcified coronary lesions, presenting various techniques and tools to address this common challenge. It covers topics such as the use of drug-coated balloons, rotational atherectomy, intravascular lithotripsy, and high-pressure non-compliant balloons. The session also includes a meta-analysis on the...
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
17 May 2024 – From EuroPCR 2024
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al....
TAVR in challenging anatomies
17 May 2024 – From EuroPCR 2024
This session focuses on navigating TAVR procedures in complex anatomical scenarios. It covers topics such as optimizing the position of a TAVR valve in a stentless bioprosthesis, managing an unexpected deep position of a TAVR implant, dealing with a completely radiolucent failing surgical bioprosthetic valve, and...
ACS: how to approach special clinical scenarios
17 May 2024 – From EuroPCR 2024
This session focuses on the management of acute coronary syndrome (ACS) in special clinical scenarios. It covers topics such as treating ACS with multivessel disease, managing an ACS and unstable patient, and addressing subacute myocardial infarction. The session features case presentations and discussions, providing insights and...
Thrombus management in a STEMI patient with high clot burden
17 May 2024 – From EuroPCR 2024
Discover the optimal timing for thrombus extraction and explore effective strategies for managing large thrombi. Learn about the latest tools and techniques, as well as the role of pharmacotherapy in supporting successful thrombus removal.
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
Andreas Grüntzig Ethica Award ceremony
15 May 2024 – From EuroPCR 2024
This session is the Andreas Grüntzig Ethica Award ceremony.
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
Valve-in-valve: utility of splitting devices
15 May 2024 – From EuroPCR 2024
This session focuses on the use of specialized splitting devices for transcatheter aortic valve-in-valve procedures. It features a case series demonstrating the application of a dedicated splitting device in failed TAVI valves, as well as the use of the BASILICA technique for transcatheter aortic valve replacement....
TEER for primary mitral regurgitation - LIVE case
15 May 2024 – From EuroPCR 2024
A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...
Devices in pulmonary embolism - Why you should be interested!
15 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...
Jon DeHaan Foundation Award ceremony
14 May 2024 – From EuroPCR 2024
This session is the Jon DeHaan Foundation Award ceremony, recognizing and celebrating outstanding achievements in the field of interventional cardiology.
The ARC consensus on DCB - evidence-based DCB technology
15 May 2024 – From EuroPCR 2024
In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.
Imaging-guided PCI for stent failure - LIVE case
16 May 2024 – From EuroPCR 2024
An 86-year-old male with PAD, a stroke in 2007, and a history of LAD PCI in 2006, presented with unstable angina due to LAD stent restenosis involving D1 and D2, with preserved LV function.
Guided by OCT, the operators performed stenosis preparation using IVL, treated the distal...
Patient management before, during, and after transcatheter tricuspid valve replacement
16 May 2024 – From EuroPCR 2024
In this session, explore key aspects of transcatheter tricuspid valve replacement, including the role of right ventricular function, pre-procedural hemodynamics, and factors that contribute to procedural success or failure, and gain insights into patient selection criteria, essential imaging techniques, and best practices for post-procedural care, both...
Asymptomatic severe aortic stenosis: Will these trials change my practice?
16 May 2024 – From EuroPCR 2024
This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of...
